Cheng Cheng, Ph.D.

Staff Scientist 

Contact: For contact information, search the NIH Enterprise Directory.


Ph.D., Nagoya University

Languages Spoken: Chinese, Japanese


As leader of the HIV-1 Vaccine Group, Dr. Cheng is responsible for developing HIV-1 vaccine candidates that elicit neutralizing antibodies. The group focuses on structure-based design of immunogens to target vulnerable sites of the native spike of HIV-1. The vaccine candidates are evaluated in animal models and in human clinical trials.